| Literature DB >> 33800622 |
Stefano Dall'Acqua1, Kouadio Ibrahime Sinan2, Stefania Sut1, Irene Ferrarese1, Ouattara Katinan Etienne3, Mohamad Fawzi Mahomoodally4, Devina Lobine4, Gokhan Zengin2.
Abstract
Croton hirtus L'Hér methanol extract was studied by NMR and two different LC-DAD-MSn using electrospray (ESI) and atmospheric pressure chemical ionization (APCI) sources to obtain a quali-quantitative fingerprint. Forty different phytochemicals were identified, and twenty of them were quantified, whereas the main constituents were dihydro α ionol-O-[arabinosil(1-6) glucoside] (133 mg/g), dihydro β ionol-O-[arabinosil(1-6) glucoside] (80 mg/g), β-sitosterol (49 mg/g), and isorhamnetin-3-O-rutinoside (26 mg/g). C. hirtus was extracted with different solvents-namely, water, methanol, dichloromethane, and ethyl acetate-and the extracts were assayed using different in vitro tests. The methanolic extracts presented the highest 1,1-diphenyl-2-picrylhydrazyl (DPPH), 2,2'-azino-bis(3-ethylbenzothiazoline)-6-sulfonic acid (ABTS), and ferric reducing antioxidant power (FRAP) values. All the tested extracts exhibited inhibitory effects on acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), with a higher activity observed for dichloromethane (AChE: 5.03 and BChE: 16.41 mgGALAE/g), while the methanolic extract showed highest impact against tyrosinase (49.83 mgKAE/g). Taken together, these findings suggest C. hirtus as a novel source of bioactive phytochemicals with potential for commercial development.Entities:
Keywords: Croton hirtus; bioactive agents; enzyme; flavonoid glycosides
Year: 2021 PMID: 33800622 PMCID: PMC8038089 DOI: 10.3390/molecules26071902
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
NMR data obtained from 1D and 2D NMR experiments and assignments of constituents identified in Croton hirtus extract. COSY, correlation spectroscopy.
| Compound No. | Compounds or Class of Compounds | δ H | δ c | Correlations in HMBC or COSY |
|---|---|---|---|---|
|
| ||||
| 2 | 7.53 | 115 | 167.0 (HMBC); 7.48 (COSY) | |
| 5 | 6.90 | 115.4 | 7.48 (COSY) | |
| 6 | 7.48 | 124.7 | 167.0 (HMBC) 7.53; 6.90 (COSY) | |
|
| ||||
| 7 | 7.59 | 143.9 | 167.5; 130.0 (HMBC); 6.45 (COSY) | |
| 8 | 6.45 | 115.6 | 127.4; 7.59 (COSY) | |
| Aromatic ring protons | 7.14–6.80 | 127.5, 122.3 114.7, 115.6 | 145.3, 151.0; 127.0, 145; 114 (HMBC) | |
|
| ||||
| H 6-8 of glycosidic flavonols | 6.10–6.22 | 98.5–99.7 | 165–155 99 101 (HMBC) | |
| Ring B quercetin | 7.40–6-23 | 115.0, 129, 125, 118 | 150.0, 145.3, 131.0 (HMBC) | |
| Ring B kaempferol (HMDB0005801) | 7.98 | 130.5 | 165.0, 130.5 (HMBC); 6.80 (COSY) | |
| 6.80 | 115.0 | 115; 7.98 (COSY) | ||
|
| ||||
| Anomeric positions | 4.85 | 109.5 | ||
| 4.67 | 99.8 | 165.0–160 (HMBC with position 7 of flavonol moieties); 3.30–3.40 (COSY) | ||
| 4.43-4.50 | 101.7 | 133.8 (HMBC with position 3 of flavonol moieties); 3.18 (COSY) | ||
| 4.22 | 104.7 | 3.18–3.28 (COSY) | ||
| 5.42 | 103 | 133.5 (HMBC position 3 flavonol) | ||
| Anomeric positions | ||||
| H-1 (rhamnose) | 4.60 brs | 99.7 | 3.18 (COSY) | |
| H-1 (hexose or pentose) | 4.50–4.70 d | 100.0–101.1 | 3.16, 3.23 (COSY) | |
| H-1 (hexose or pentose) | 4.50–4.70 | 100.0–101.1 | 3.16, 3.23 (COSY) | |
| H-6 (hexose) free position | 3.30–3.50 | 60.5 | ||
| H-6 (hexose) glycosidic linked | 3.30–3.50 | 64.5 | ||
| CH bearing ester linkage (from sugar residue) | 4.95 | 73.4 | 165, 104, 71 | |
| CH bearing ester linkage (from sugar residue) | 5.08 | 71.2 | 165, 89, 63 | |
|
| ||||
| H-2 Icariside B | 5.85–5.90 | 128.7 | 200, (HMBC) | |
| CH2-6 Icariside B | 2.58 | 54.0 | 200, 72.0 (HMBC) | |
| CH3 Icariside B | 1.02 | 24.2 | 77 (HMBC) | |
| H-7 Corchionoside | 5.75 | 125.7 | ||
| H-8 Corchionoside | 5.86 | 131.9 | ||
| CH3 Corchioside | 1.21 | 19.6 | 73.0, 125.7 (HMBC) | |
|
| ||||
| H3 | 5.30, 5.2 | 127.5 | 141, 59, 36 (HMBC) | |
| CH3 linked to double bond | 2.02 | 20.5 | 141, 127 | |
| Geminal methyl groups, secondary methyl group of the butanol chain | 0.95–1.04 | 23.9–24.1 | 36.0 51.0 72.0 | |
|
| ||||
| terminal methyl groups | 0.93 | 17.5 | 40.0, 23.0 | |
| CH2 | 2.02 | 19.5 | 24.2, 30.0 | |
| sp2 | 5.35–5.40 | 122.5 |
Figure 1Heteronuclear single quantum coherence- Distortionless enhancement by polarization transfer, (HSCQ-DEPT) portion of the spectrum showing the signals ascribable to phenolic derivatives.
Figure 2HSQC-DEPT portion of spectrum showing some of the diagnostic signals used to confirm structure identification.
Figure 3Diffusion order spectroscopy (DOSY) spectrum showing some of the different classes of constituents present in the C. hirtus extract.
Figure 4LC-DAD chromatogram (330 nm) showing the peak group assigned to small phenolics, flavonoids, and phenylpropanoid derivatives; exemplificative UV spectra of the peaks are included. Peaks numbers refer to Table 2.
Identification and quantification of compounds in methanolic extract of Croton hirtus. * compared with authentic standard.
| Compound No. | Retention Time | [M − H]− | Fragments | Formula | Identification and Reference | mg/g |
|---|---|---|---|---|---|---|
|
| ||||||
| 1 | 16.5 | 755 | 593 300(300→271 255 179 151) (271→243 227) | C33H40O20 | Quercetin-3- | 0.61 ± 0.01 |
| 2 | 19.1 | 755 | 593 300 (300→271 255 179 151) (271→243 227) | C36H36O18 | Quercetin-3-deoxyhexoside-hexoside- deoxyhexoside | 0.22 ± 0.01 |
| 3 | 18.9 | 609 | 301 300 (301→271 255 179 151) (271→243 227) | C27H30O16 | Quercetin-hexoside-deoxyhexoside | 1.59 ± 0.05 |
| 4 | 18.5 | 739 | 593 577 447 430 285 257 | C33H40O19 | Kaempferol-7- | 3.68 ± 0.04 |
| 5 | 19.4 | 755 | 609 591 489 300 271 255 | C36H36O18 | Quercetin-3-deoxyhexoside-hexoside- | 3.64 ± 03.04 |
| 6 | 18.5 | 595 | 463 300 271 255 (300→271 255) (271→243 227 215 199) | C26H28O16 | Quercetin-3-apiofuranosyl-glucopyranoside | 16.13 ± 0.04 |
| 7 | 19.3 | 609 | 301 447 285 255 | C27H30O16 | Rutin* | 3.02 ± 0.04 |
| 8 | 20.5 | 579 | 447 429 285 (285→255) (255→227 213 211 187) | C25H28O15 | Kaempferol-3- | 2.52 ± 0.06 |
| 9 | 19.9 | 463 | 301 229 179 | C21H20O12 | Quercetin-3- | 4.21 ± 0.03 |
| 10 | 23.1 | 623 | 315 300 299 271 255 243 (315→300 272 255) | C28H30O16 | Isorhamnetin-3- | 25.91 ± 0.09 |
| 11 | 21.6 | 609 | 315 301 (301→271 255 179 151) (271→243 227) | C27H30O16 | Isorhamnetin -3- | 4.93 ± 0.03 |
| 12 | 22.3 | 447 | 301 255 | C21H20O11 | Quercetin-3- | 1.39 ± 0.04 |
| 13 | 23.5 | 477 | 314 285 271 | C21H20O11 | Isorhamnetin-7- | 4.46 ± 0.06 |
| 14 | 25.8 | 447 | 314 285 271 (314→300 285 271) | C21H20O11 | Isorhamnetin-7- | 1.97 ± 0.03 |
| 15 | 21.6 | 593 | 447 285 | C27H30O15 | Kaempferol-3- | 18.00 ± 0.09 |
| 16 | 18.4 | 329 | 314 299 271 243 226 199 | C17H18O7 | Dimethoxy quercetin | 4.49 ± 0.02 |
|
| ||||||
| 17 | 2.3 | 341 | 179 | C15H18O9 | Caffeic acid hexoside | 4.36 ± 0.04 |
| 18 | 5.8 | 315 | 153 | C13H16O9 | Protocatechuic acid hexoside | 5.66 ± 0.03 |
| 19 | 7.8 | 401 | 269 161 | C20H18O9 | Benzyl alcohol hexose pentose | 4.04 ± 0.05 |
| 20 | 11.28 | 487 | 337 279 261 | C21H28O13 | Synapoyl pentose-pentose | 1.08 ± 0.02 |
| 21 | 17.2 | 431 | 261 187 (187→125) (125→97) | Gallic acid benzoic acid derivative | 8.84 ± 0.03 | |
| 22 | 19.4 | 769 | 605 475 315 299 | C35H46O19 | Leonoside A | 10.04 ± 0.02 |
| 23 | 20.4 | 755 | 623 593 315 297 | C34H44O19 | Forsythoside B | 6.31 ± 0.05 |
| 24 | 32.6 | 797 | 603 474 456 327 167 | C37H50O19 | Ferruginoside C isomer | 7.60 ± 0.05 |
| 25 | 35.5 | 797 | 603 474 456 327 167 | C37H50O19 | Ferruginoside C | 14.21 ± 0.08 |
| 26 | 33.9 | 663 | 517 485 467 | C31H36O16 | Feruloyl-coumaroyl saccharose | 15.97 ± 0.08 |
| 27 | 36.4 | 663 | 517 485 467 | C31H36O16 | Feruloyl-coumaroyl saccharose | 12.21 ± 0.08 |
| 28 | 39.9 | 663 | 517 485 467 | C31H36O16 | Feruloyl-coumaroyl saccharose | 11.20 ± 0.06 |
| 29 | 41.5 | 663 | 517 485 467 | C31H36O16 | Feruloyl-coumaroyl saccharose | 13.06 ± 0.09 |
| 30 | 44.2 | 663 | 517 485 467 | C31H36O16 | Feruloyl-coumaroyl saccharose | 9.06 ± 0.07 |
|
| ||||||
| 31 | 13.1 | 433 [M + HCOOH − H]− | 387.5 223 205 161 153 (153→138–122) | C19H32O8 + CH2O2 | Icariside B5 | 9.15 ± 0.06 |
| 32 | 13.9 | 431 [M + HCOOH − H]− | 385.5 223 205 161 153 (153→138–122) | C19H30O8 + CH2O2 | Corchoionoside C/Roseoside | 3.63 ± 0.06 |
| 33 | 22.97 | 487 | 355 337 289 279 261 167 | C24H40O10 | dihydro α ionol- | 132.72 ± 0.11 |
| 34 | 24.07 | 487 | 355 337 289 271 | C24H40O10 | dihydro β ionol- | 79.57 ± 0.11 |
| 35 | 53.4 | 331 | 295 277 215 185 | C20H28O4 | Kongensin D | 0.72 ± 0.02 |
|
|
| |||||
| [M − H20 + H]+ | ||||||
| 36 | 60.0 | 397 | C29H50O | β-sitosterol* | 48.60 ± 0.14 | |
| 37 | 53.8 | 383 | C28H48O | Campesterol* | 3.04 ± 0.08 | |
| 38 | 51.3 | 399 | C29H52O | Stigmastanol* | 4.37 ± 0.08 | |
Figure 5Spectral and fragmentations of icariside B5: MS2 from parent ion 387 m/z, MS3 from fragment 153 m/z, MS4 from fragment 138 m/z.
Figure 6Spectra and fragmentations proposed for corchoionoside C: MS1 from parent ion 385 m/z, MS2 from fragment 153 m/z.
Figure 7Mass spectral details of dihydro α ionol-O-[arabinosil(1-6) glucoside].
Figure 8Mass spectral details of dihydro β ionol-O-[arabinosil(1-6) glucoside].
Extraction yields and total bioactive components in the tested extracts *.
| Extracts | Extraction Yields (%) | Total Phenolic Content (mg GAE/g) | Total Flavonoid Content (mg RE/g) |
|---|---|---|---|
| DCM | 2.13 | 24.24 ± 0.90 a | 14.37 ± 0.12 c |
| EA | 2.34 | 22.51 ± 0.52 b | 29.28 ± 1.89 b |
| Infusion | 9.95 | 22.38 ± 0.34 b | 12.54 ± 0.32 c |
| MeOH | 13.18 | 17.96 ± 0.03 c | 50.16 ± 2.53 a |
* Values expressed are means ± S.D. of three parallel measurements. GAE: Gallic acid equivalent; RE: Rutin equivalent. Different letters indicate significant differences in the extracts (p < 0.05).
Antioxidant properties of the tested extracts *.
| Extracts | DPPH (mgTE/g) | ABTS (mgTE/g) | CUPRAC (mgTE/g) | FRAP (mgTE/g) | Phosphomolybdenum (mmol TE/g) | Chelating Ability (mg EDTAE/g) |
|---|---|---|---|---|---|---|
| DCM | 22.78 ± 0.52 c | 32.32 ± 2.49 c | 88.67 ± 1.08 a | 26.35 ± 0.09 c | 2.70 ± 0.13 a | 15.18 ± 1.08 b |
| EA | 23.66 ± 1.14 c | 18.59 ± 1.64 d | 69.04 ± 0.40 c | 24.15 ± 0.21 d | 2.33 ± 0.27 ab | 18.26 ± 0.22 a |
| Infusion | 41.08 ± 1.65 a | 64.84 ± 2.71 a | 78.17 ± 0.16 b | 45.67 ± 0.86 a | 1.46 ± 0.01 c | 17.94 ± 0.16 a |
| MeOH | 30.62 ± 0.54 b | 42.02 ± 1.11 b | 62.50 ± 2.30 d | 30.94 ± 0.35 b | 1.97± 0.10 b | 13.96 ± 0.10 b |
* Values expressed are means ± S.D. of three parallel measurements. TE: Trolox equivalent; EDTAE: EDTA equivalent. Different letters indicate significant differences in the extracts (p < 0.05).
Enzyme inhibitory properties of the tested extracts *.
| Extracts | AChE Inhibition (mgGALAE/g) | BChE Inhibition | Tyrosinase Inhibition (mgKAE/g) | Amylase Inhibition (mmolACAE/g) | Glucosidase Inhibition (mmol ACAE/g) |
|---|---|---|---|---|---|
| DCM | 5.03 ± 0.16 a | 16.41 ± 1.68 a | 24.39 ± 0.98 c | 0.71 ± 0.01 ab | 1.68 ± 0.14 |
| EA | 4.84 ± 0.19 a | 15.86 ± 0.74 a | 34.81 ± 2.67 b | 0.75 ± 0.03 a | na |
| Infusion | 1.01 ± 0.13 c | 14.44 ± 0.34 a | na | 0.14 ± 0.01 c | na |
| MeOH | 4.09 ± 0.02 b | 16.11 ± 0.25 a | 49.83 ± 3.94 a | 0.69 ± 0.02 b | na |
* Values expressed are means ± S.D. of three parallel measurements. GALAE: Galatamine equivalent; KAE: Kojic acid equivalent; ACAE: Acarbose equivalent. na: not active. Different letters indicate significant differences in the extracts (p < 0.05).
Figure 9A k-medoids clustering analysis of biological activities of C. hirtus. (A) Distance matrix showing the dissimilarity between each pair of subjects (Red color: high similarity, Blue color: low similarity). (B) Number of clusters. (C) Scatter plot. (D) Silhouette plot displaying the average distance between clusters.